FOXO3 and glioblastoma: Interestingly, a recent study identified a GBM subtype based on an oxPhos metabolic phenotype that shows selective vulnerability to mitochondrial inhibitors.42 Moreover, aging is also associated with changes in mitochondrial function.80 Our data suggest a role for FOXO3 in restraining this mitochondrial-associated phenotype, particularly in the context of aging.